Life Extension Neuro-Mag Magnesium L-Threonate Review

Magnesium L-Threonate (Magtein) is the magnesium salt of L-threonic acid (a vitamin C metabolite). The threonate molecule chaperones magnesium through the blood-brain barrier in a way that bisglycinate, citrate, oxide, malate, and taurate cannot — the Slutsky 2010 MIT paper that anchored this category showed brain-magnesium levels increasing measurably in rats only with threonate, not other forms. That's the entire pitch: same elemental Mg, but it gets to brain tissue where it can act on NMDA-receptor density and synaptic plasticity.

Increased brain magnesium concentrations regulate NMDA glutamate receptor density — the receptor system underlying memory formation, learning, and synaptic plasticity. In aging brains, NMDA-receptor density drops; threonate-driven Mg restoration appears to slow that decline. The Liu 2016 trial in older adults showed ~9% improvement on executive function tests after 12 weeks at 2000 mg Magtein/day. The effect is modest but reproducible and dose-correlated.

Magtein delivers 144 mg elemental magnesium per 2000 mg of L-threonate compound (3 caps) — that's a low elemental yield because threonate is a heavy carrier molecule. Compare to bisglycinate which is ~14% elemental by weight. For BBB-crossing, the threonate is the feature, not a bug — but if you want PERIPHERAL magnesium effects (sleep, cramps, blood pressure, bone), this is the wrong form. Stack Neuro-Mag with a bisglycinate at PM for full coverage.

In addition. The use cases barely overlap. Glycinate is for sleep, anxiety, cramps, and HPA-axis support — peripheral magnesium effects. Threonate is for cognition, memory, and synaptic plasticity — central nervous system effects. The same elemental Mg molecule, but routed differently. Most users running both stack: Magtein 2000 mg AM (cognition through the day) + bisglycinate 240-400 mg PM (sleep). $50/month total at this tier.

Cognitive effects are subtle and slow. The Liu 2016 trial showed measurable improvement on executive function tests at 12 weeks. Subjective reports (better word recall, less brain fog) typically land at 4-6 weeks. If you're expecting same-day cognitive sharpening like caffeine + L-theanine, you'll be disappointed. The threonate signal is structural (NMDA-receptor density changes) — slower onset, longer half-life of benefit.

Yes — but verify the label. Magtein is the only L-Threonate trade name with published RCTs (Slutsky 2010, Liu 2016) backing the BBB-crossing claim. Generic 'magnesium L-threonate' bottles on Amazon are increasingly common at half the price, but the chemistry isn't all the same — Magtein's specific stereoisomer is what the trials measured. Cheaper generics MAY work; only Magtein is the form with trial backing. Life Extension's Neuro-Mag uses verified Magtein.

3 capsules per day = 2000 mg Magtein = 144 mg elemental Mg. This is the dose used in Liu 2016 trial and is the standard threonate protocol. Most users take all 3 caps AM or split 2 AM + 1 mid-afternoon. Evening dosing can be slightly stimulating in some users (brain Mg can briefly boost alertness), so AM/early-PM timing is safer if you're sleep-sensitive.

1. [1] Slutsky 2010 PMID 20152124 — Enhancement of learning and memory by elevating brain magnesium. The MIT paper that anchored the magnesium L-threonate category. Showed brain-Mg levels increase only with L-threonate (not other forms) in rats, with downstream effects on NMDA-receptor density, synaptic plasticity, and learning + memory. The foundational paper.
2. [2] Liu 2016 PMID 26519439 — Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults. Human RCT in older adults: 2000 mg Magtein/day for 12 weeks improved executive function by ~9% on standardized tests vs placebo. The trial that anchors the human cognitive evidence for L-threonate.
3. [3] Abumaria 2011 PMID 22016520 — Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity. Follow-up to Slutsky 2010 — L-threonate-driven brain-Mg elevation enhanced fear extinction (clinical relevance for anxiety/PTSD) and synaptic plasticity in prefrontal cortex. Expands the mechanistic case beyond just memory.
4. [4] Held 2002 PMID 12163983 — Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Reference trial for peripheral Mg sleep effects — frames why bisglycinate is the right form for sleep and why threonate is a different category.
5. [5] Rosanoff 2012 PMID 22364157 — Suboptimal magnesium status in the United States. Population-level case for magnesium supplementation broadly. Frames why even threonate users should ensure peripheral Mg adequacy via diet or a bisglycinate co-supplement.
6. [6] Uwitonze 2018 PMID 29480918 — Role of magnesium in vitamin D activation and function. Magnesium is the obligate cofactor for vitamin D activation. Relevant context for users running Neuro-Mag — peripheral Mg from diet or co-supplement is still needed to support D3 utilization.